Previously the Live Forever Club — same community, now with a sharper mission for life extension

Liverpool opens £20m robot lab to speed up drug and vaccine research

Laboratory automation and mini organs aim to cut animal testing in Liverpool

04-Sep-2026

Key points from article :

A new £20m robotic laboratory at the Liverpool School of Tropical Medicine (LSTM) aims to speed up the development of drugs, vaccines and diagnostic tests for infectious diseases, while reducing the need for animal testing. The Liverpool Accelerate Laboratory, developed with the Infection Innovation Consortium (iiCON), was officially opened in early September and is due to be fully running in 2027.

Instead of relying on animals, the lab will test treatments on organoids, tiny lab-grown versions of human organs made from donated human tissue. Researchers say these give a more accurate picture of how a treatment will behave in people. Robots, automated liquid-handling systems and AI will run and analyse experiments at a scale and speed that would be hard to match by hand. Giancarlo Biagini, LSTM's pro-vice chancellor for research and innovation, said the facility would accelerate the way drugs, vaccines and diagnostics are developed.

The facility is a high-security Containment Level 3 lab, so scientists can study dangerous pathogens such as tuberculosis and salmonella there. Because robots handle much of the work, large experiments on these infections can be run without staff being directly exposed. Janet Hemingway, iiCON's founding director, said automating routine tasks would free researchers to focus on improving the science, and that the project would create several hundred technology jobs.

The lab is open to companies of all sizes, and iiCON will support early pilot studies, which could help smaller firms and start-ups that could not otherwise afford such equipment. Half of the funding, £10m, came from the Liverpool City Region Life Sciences Innovation Zone, and the lab is expected to attract £40m of investment in its first three years.

The lab is not yet fully operational, and its promised gains in speed have still to be shown in practice. Organoids are a promising alternative to animal models, but they cannot yet capture every aspect of a whole living body, so animal testing is likely to be reduced rather than ended.

Mentioned in this article:

Click on resource name for more details.

Giancarlo Biagini

Pro-vice chancellor for research and innovation at the Liverpool School of Tropical Medicine who works on drug discovery for infectious diseases

Infection Innovation Consortium (iiCON)

Liverpool-based consortium led by LSTM that links industry, academia and the NHS to develop new treatments and tests for infections

Janet Hemingway

Founding director of the Infection Innovation Consortium (iiCON) and former director of the Liverpool School of Tropical Medicine

Liverpool School of Tropical Medicine (LSTM)

Liverpool institution founded in 1898 that researches and teaches tropical medicine and infectious diseases

Topics mentioned on this page:
Laboratory Automation, Drug Discovery
Liverpool opens £20m robot lab to speed up drug and vaccine research
DoNotAge supplements affiliate link